Latest filing published 11 May 2023 for 瑞康医药, €7.3M.
Filing timeline
BuySaleInsider track record
张仁华: trading record in brief
All filings by 张仁华 on record concern 瑞康医药, in the capacity of chief executive. In total, 4 filings cover trades dated from 28 March 2022 to 11 May 2023.
On the market, this insider has only sold: 4 sales, €26.9M in total. So far in 2023, the count stands at no purchases and 2 sales.
Most recently, on 11 May 2023, the filings show an open-market sale worth €7.3M in 瑞康医药. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 张仁华
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000,000 shares27.2% of flowA股XSHESZSE:173000006588598820
- 13,040,000 shares23.5% of flowA股XSHESZSE:173000006420235800
- 8,000,000 shares16.1% of flowA股XSHESZSE:173000005952608930
- 16,000,000 shares33.2% of flowA股XSHESZSE:173000006591157250
4 of 4 declarations